Empagliflozin and Malaise - a phase IV clinical study of FDA data

Summary:

Malaise is reported as a side effect among people who take Empagliflozin (empagliflozin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Diabetes.

The phase IV clinical study analyzes which people have Malaise when taking Empagliflozin. It is created by eHealthMe based on reports of 1,555 people who have side effects when taking Empagliflozin from the FDA, and is updated regularly.

What is Empagliflozin?

Empagliflozin has active ingredients of empagliflozin. eHealthMe is studying from 1,569 Empagliflozin users. Check the latest studies of Empagliflozin.

What is Malaise?

Malaise (a feeling of general discomfort or uneasiness) is found to be associated with 3,484 drugs and 5,129 conditions by eHealthMe. Check the latest studies of Malaise.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,555 people reported to have side effects when taking Empagliflozin.
Among them, 28 people (1.8%) have Malaise.

Among these 28 people:

How long have people been on Empagliflozin when they have Malaise? *

What is the gender of people who have Malaise when taking Empagliflozin? *

female: 40.74 %
male: 59.26 %

What is the age of people who have Malaise when taking Empagliflozin? *

What are other drugs people take besides Empagliflozin? *

What are other side effects people have besides Malaise? *

Weakness: 11 people, 39.29%
Fatigue (feeling of tiredness): 10 people, 35.71%
Headache (pain in head): 7 people, 25.00%
Weight Increased: 7 people, 25.00%
Nerve Injury: 6 people, 21.43%
Peripheral Swelling: 6 people, 21.43%
Neuralgia (pain in one or more nerves): 6 people, 21.43%
Stress And Anxiety: 5 people, 17.86%
Back Pain: 5 people, 17.86%
Depression: 5 people, 17.86%

What are the existing conditions these people have? *

Diabetes: 7 people, 25.00%
Type 2 Diabetes: 3 people, 10.71%
Cardiac Failure: 3 people, 10.71%
Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 2 people, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 3.57%
Neuropathy Peripheral (surface nerve damage): 1 person, 3.57%
Breast Cancer: 1 person, 3.57%
Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Empagliflozin and have Malaise?

- Check whether Malaise is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Empagliflozin:

Empagliflozin (1,569 reports)

Malaise treatments and more:

Malaise (529,933 reports)

Browse all side effects of Empagliflozin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malaise:

Malaise (3,484 drugs)

Browse all the conditions that are associated with Malaise:

Malaise (5,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on empagliflozin (the active ingredients of Empagliflozin) and Empagliflozin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.